Project Number 5P50AG005142-30 Agency/Funding Organization NIA Funding Year 2014 View Full Project Details for NOVEL NEUROSERMS AND NEUROARMS FOR PROTECTION AGAINST AZLHEIMER PATHOLOGY Research Categorization Primary Disease / Condition Alzheimer's Disease Vascular Dementia/Dysfunction CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) l. Growth Factors and Hormones Category F. Research Resources 1. Alzheimer's Disease Centers Researcher and Organization Principal Investigator BRINTON, ROBERTA EILEEN Principal Investigator First Name ROBERTA Principal Investigator Last Name BRINTON Awardee Organization UNIVERSITY OF SOUTHERN CALIFORNIA Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-10-002: ALZHEIMER'S DISEASE RESEARCH CENTERS (P50) FY Overall Cost $212,291 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PHELPS, CREIGHTON H. Related Resources Repository [NIAGADS] Transethnic GWAS Summary Statistics - Jun et al. (2017) [NIAGADS] ADGC African American Summary Statistics- Reitz et al. (2013) [NIAGADS] ADGC Neuropath Summary Stats and Phenotypes- Beecham et al. (2014) [NIAGADS] ADGC Summary Statistics- Naj et al. (2011) [NIAGADS] ADC1- Alzheimer Disease Center Dataset 1 [NIAGADS] ADC2- Alzheimer Disease Center Dataset 2 [NIAGADS] ADC3- Alzheimer Disease Center Dataset 3 University of Southern California Alzheimer's Disease Research Center National Alzheimer's Coordinating Center (NACC) [AlzPED] Docosahexaenoic Acid Protects from Dendritic Pathology in an Alzheimer’s Disease Mouse Model
